BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20181227)

  • 21. p16
    Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease.
    Murao K; Yoshioka R; Kubo Y
    J Dermatol; 2014 Oct; 41(10):878-84. PubMed ID: 25201325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
    Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
    Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
    JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
    Huho AN; Yadak N; Bocklage TJ; Yang S
    J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas.
    Kim Y; Joo YH; Kim MS; Lee YS
    J Pathol Transl Med; 2020 Sep; 54(5):411-418. PubMed ID: 32683856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia.
    Argirion I; Zarins KR; McHugh J; Cantley RL; Teeramatwanich W; Laohasiriwong S; Kasemsiri P; Naruikon J; Srimanta P; Chinn SB; Vatanasapt P; Rozek LS
    J Clin Virol; 2020 Nov; 132():104637. PubMed ID: 32932151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival.
    Benzerdjeb N; Traverse-Glehen A; Philouze P; Bishop J; Devouassoux-Shisheboran M
    Histopathology; 2020 Mar; 76(4):581-591. PubMed ID: 31463946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
    Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
    Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
    Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal.
    Serup-Hansen E; Linnemann D; Skovrider-Ruminski W; Høgdall E; Geertsen PF; Havsteen H
    J Clin Oncol; 2014 Jun; 32(17):1812-7. PubMed ID: 24821878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
    Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
    Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
    Halec G; Schmitt M; Dondog B; Sharkhuu E; Wentzensen N; Gheit T; Tommasino M; Kommoss F; Bosch FX; Franceschi S; Clifford G; Gissmann L; Pawlita M
    Int J Cancer; 2013 Jan; 132(1):63-71. PubMed ID: 22514107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation.
    Kim TW; Choi SY; Ko YH; Baek CH; Son YI
    Clin Exp Otorhinolaryngol; 2012 Dec; 5(4):207-12. PubMed ID: 23205225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
    Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
    Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.